Chargement en cours...
Localized Interleukin-12 for Cancer Immunotherapy
Interleukin-12 (IL-12) is a potent, pro-inflammatory type 1 cytokine that has long been studied as a potential immunotherapy for cancer. Unfortunately, IL-12's remarkable antitumor efficacy in preclinical models has yet to be replicated in humans. Early clinical trials in the mid-1990's sh...
Enregistré dans:
| Publié dans: | Front Immunol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7593768/ https://ncbi.nlm.nih.gov/pubmed/33178203 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.575597 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|